Lantern Pharma Inc. Public Float
Lantern Pharma Inc. (LTRN) had Public Float of $33.94 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $33.94M.
- 2024-06-28: Entity Public Float $44.29M.
- 2023-06-30: Entity Public Float $52.57M.
- 2022-06-30: Entity Public Float $51.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $33.94M 10-K/A · filed 2026-04-30 |
| 2024-06-28 | $44.29M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $52.57M 10-K · filed 2024-03-18 |
| 2022-06-30 | $51.00M 10-K · filed 2023-03-20 |
| 2021-06-30 | $121.72M 10-K · filed 2022-03-10 |
| 2020-06-30 | $34.73M 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |